BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manzia TM, Angelico R, Gazia C, Lenci I, Milana M, Ademoyero OT, Pedini D, Toti L, Spada M, Tisone G, Baiocchi L. De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World J Gastroenterol 2019; 25(35): 5356-5375 [PMID: 31558879 DOI: 10.3748/wjg.v25.i35.5356] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Kim YJ, Jung CJ, Park GH, Won CH, Chang SE, Choi JH, Lee MW, Lee WJ. Twenty-eight-year incidence and characteristics of post-transplant skin cancers: Comparative analysis of past and recent 10-year experience. J Dermatol 2020;47:1131-40. [PMID: 32720388 DOI: 10.1111/1346-8138.15483] [Reference Citation Analysis]
2 Cui X, Geng XP, Zhou DC, Yang MH, Hou H. Advances in liver transplantation for unresectable colon cancer liver metastasis. World J Gastrointest Surg 2021; 13(12): 1615-1627 [DOI: 10.4240/wjgs.v13.i12.1615] [Reference Citation Analysis]
3 Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Yoon YI, Cho HD, Kwon JH, Chung YK, Kang SH, Choi JU, Jung IJ, Lee SG. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation. J Korean Med Sci 2020;35:e69. [PMID: 32193900 DOI: 10.3346/jkms.2020.35.e69] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shalaby S, Burra P. De novo and recurrent malignancy. Best Pract Res Clin Gastroenterol 2020;46-47:101680. [PMID: 33158464 DOI: 10.1016/j.bpg.2020.101680] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Bryan N, Zandieh A, Kallakury B, Kaufman S, Yazigi N, Girlanda R, Hawksworth J, Fishbein T, Matsumoto C, Kroemer A, Khan K. De novo hepatocellular carcinoma 18 years after liver and small bowel transplantation in a one-year-old pediatric patient. Pediatr Transplant 2021;25:e13820. [PMID: 32844551 DOI: 10.1111/petr.13820] [Reference Citation Analysis]
6 Toniutto P, Germani G, Ferrarese A, Bitetto D, Zanetto A, Fornasiere E, Fumolo E, Shalaby S, Burra P. An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know. Am J Med 2021:S0002-9343(21)00561-1. [PMID: 34508700 DOI: 10.1016/j.amjmed.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Didilescu AC, Vacaru RP, Pronk C, Scheau C, Lazu A, Dan LP, Brand HS. Oral diseases after liver transplantation: a systematic review and meta-analysis. Br Dent J 2021;231:117-24. [PMID: 34302095 DOI: 10.1038/s41415-021-3219-1] [Reference Citation Analysis]
8 Bakhtiyar S, Batra A, Malik T, Cotton R, Galvan NT, O'Mahony C, Goss J, Rana A. Three decades' analysis of pediatric liver transplantation outcomes reveals limited long-term improvements. Pediatr Transplant 2021;:e14158. [PMID: 34698432 DOI: 10.1111/petr.14158] [Reference Citation Analysis]
9 Rela M, Quintero J, Kasahara M, Muiesan P, Hernández-Oliveros F, Rajalingam R, Shankar S, Sayed BA, di Sabato D, Rammohan A, Fung J, Bilbao I. Nonhepatic Cancer in the Pediatric Liver Transplant Population: Guidelines From the ILTS-SETH Consensus Conference. Transplantation 2022;106:e46-51. [PMID: 34905761 DOI: 10.1097/TP.0000000000003996] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tolaymat LM, Reimer DK, Feig J, Gillis MS, Speicher LL, Haga CB, Gabriel EM, Heckman MG, Yin M, Fosko SW, Keaveny AP, Dawson NL. Skin cancer in non-white liver transplant recipients: Mayo Clinic experience. Int J Dermatol 2021;60:986-90. [PMID: 33742703 DOI: 10.1111/ijd.15519] [Reference Citation Analysis]
11 Bateman AC. Immune Checkpoint Inhibitor Therapy in Colorectal Cancer-The Role of Cellular Pathology. Int J Surg Pathol 2021;29:584-91. [PMID: 34142908 DOI: 10.1177/10668969211025844] [Reference Citation Analysis]
12 Park GC, Hwang S, Song GW, Jung DH, Moon DB, Ahn CS, Kim KH, Ha TY, Yoon YI, Lee SG. Treatment and outcomes of extrahepatic malignancy incidentally diagnosed during pretransplant evaluation for living donor liver transplantation. J Hepatobiliary Pancreat Sci 2020;27:200-10. [PMID: 31957982 DOI: 10.1002/jhbp.707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ossami Saidy RR, Postel MP, Pflüger MJ, Schoening W, Öllinger R, Gül-Klein S, Schmelzle M, Tacke F, Pratschke J, Eurich D. Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1617. [PMID: 33807392 DOI: 10.3390/cancers13071617] [Reference Citation Analysis]
14 Rigopoulou EI, Dalekos GN. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers (Basel) 2021;13:1023. [PMID: 33804480 DOI: 10.3390/cancers13051023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tangthanapalakul A, Chaijitraruch N, Techavichit P, Sosothikul D, Chatproedprai S, Chongsrisawat V, Tempark T, Wananukul S. Dermatologic manifestations in pediatric patients after liver and HSCT: A 20-year retrospective cohort study. Pediatr Transplant 2021;25:e13916. [PMID: 33142028 DOI: 10.1111/petr.13916] [Reference Citation Analysis]
16 Sun JY, Wu R, Xu J, Xue HY, Lu XJ, Ji J. Placental Immune Tolerance and Organ Transplantation: Underlying Interconnections and Clinical Implications. Front Immunol 2021;12:705950. [PMID: 34413856 DOI: 10.3389/fimmu.2021.705950] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Saglam K, Sahin TT, Ogut Z, Ince V, Usta S, Yilmaz S. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center. J Gastrointest Cancer 2021. [PMID: 34778909 DOI: 10.1007/s12029-021-00749-0] [Reference Citation Analysis]
18 Gitto S, Magistri P, Marzi L, Mannelli N, De Maria N, Mega A, Vitale G, Valente G, Vizzutti F, Villa E, Marra F, Andreone P, Di Benedetto F, Falcini M, Catellani B, Guerrini GP, Serra V, Di Sandro S, Ballarin R, Piai G, Schepis F, Margotti M, Cursaro C, De Simone P, Petruccelli S, Carrai P, Forte P, Campani C, Zoller H. Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Toti L, Manzia TM, Sensi B, Blasi F, Baiocchi L, Lenci I, Angelico R, Tisone G. Towards tolerance in liver transplantation. Best Pract Res Clin Gastroenterol 2021;54-55:101770. [PMID: 34874844 DOI: 10.1016/j.bpg.2021.101770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shimozawa K, Contreras-Ruiz L, Sousa S, Zhang R, Bhatia U, Crisalli KC, Brennan LL, Turka LA, Markmann JF, Guinan EC. Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade. Am J Transplant 2021. [PMID: 34528383 DOI: 10.1111/ajt.16842] [Reference Citation Analysis]
21 Tokalioglu AA, Ozgun YM, Celik F, Akdogan M, Bostanci EB, Turan T, Turkmen O. High Grade Serous Ovarian Carcinoma in a Liver Transplant Recipient Patient: A Case Report and Review of Literature. Transplant Proc 2022:S0041-1345(21)00897-6. [PMID: 34996597 DOI: 10.1016/j.transproceed.2021.12.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 El-Domiaty N, Saliba F, Sebagh M, Salloum C, Vibert E, Azoulay D, Hamelin J, Cherqui D, Adam R, Samuel D. De novo hepatocellular carcinoma in a non-cirrhotic allograft 27 years after liver transplantation: A case report. Am J Transplant 2021;21:1953-8. [PMID: 33382179 DOI: 10.1111/ajt.16476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]